Global Digital Store – Ebooks and Softwares

Tag: Partners

Sultan Nazrin consents to setting up of Special Zakat Distribution Fund

IPOH: The Sultan of Perak Sultan Nazrin Shah (pix) has consented to the Special Zakat Distribution Fund, involving RM11.95 million, to ease the burden of the people affected by the Covid-19 outbreak and assist efforts by various quarters in addressing the crisis.

Perak Islamic Religious and Malay Customs Council (MAIPk) chief executive oficer Shahrul Azam Shaari said the special fund was set up by the council, with the cooperation of several of its strategic partners.

This special fund, involved RM11.11 million from the zakat allocation, RM30,000 from SP Setia Foundation chairman and RM800,000 in tithe from the corporate sector,“ he said in a statement here today.

He said Sultan Nazrin consented to the setting up of the fund so that it could be used to help those who are affected by the enforcement of the Movement Control Order (MCO) which has been extended until April 14.

“Sultan Nazrin is concerned and aware that the Covid-19 pandemic has a direct impact on the lives of the people, especially among those with unstable income and those in the low-income group,“ he added.

Shahrul said the special fund would cover the cost of the Food Box Aid, involving RM240,000, which would be channeled through the Covid-19 Operations Room under the respective District and Land Offices tin the state.

He said RM5.8 million would be for the Emergency Survival Assistance, which is targeted for households earning RM2,000 and below whose income were affected due to either termination of employment, unpaid leave or other reasons.

A total of RM2 million is allocated for Special Capital Assistance to assist MAIPk traders, hawkers and entrepreneurs whose business were affected by the MCO; RM100,000 for management and welfare assistance to Perak students studying abroad and RM100, 000 to provide food supply to students at public and private institutions of higher learning in Perak who are still at their respective colleges, he added.

Shahrul said a special contribution of RM500,000 would be made to the Perak Health Department, the Royal Malaysia Police, the Malaysian Armed Forces and other agencies for the welfare of their Covid-19 frontline personnel.

RM1 million is for health and medical equipment to be donated to hospitals in Perak, RM1.5 million for purchase of medical equipment to combat Covid-19, like face masks, gloves and disinfectant to be distributed to mosques, suraus and the general public, and RM710,000 for contingency plan, he added. – Bernama

Read More
https://www.thesundaily.my/local/sultan-nazrin-consents-to-setting-up-of-special-zakat-distribution-fund-BH2180355

Views: 0

March 25, 2020
World TB Day 2020: It’s Time for solidarity
At this unique time in history when the world is grappling with the COVID-19 pandemic, the WHO Department of Global HIV, Hepatitis and STI Programmes stands in solidarity with governments and communities as they seek to maintain health services
and continue to address the needs of patients suffering from HIV and tuberculosis (TB).

Despite being preventable and treatable, tuberculosis remains the world’s biggest infectious killer and the leading cause of death among people living with HIV (PLHIV), responsible for 32% of the 770 000 lives lost to HIV in 2018. People
living with HIV are far more vulnerable (nearly 20 times more) to TB infection than people without HIV and are three times more likely to die during TB treatment.

While there are proven interventions that reduce TB deaths – such as provision of TB preventive treatment, adoption of novel diagnostics for earlier TB diagnosis and linkage to treatment, and antiretroviral therapy (ART) – we are far behind
in scaling these up, and diagnostic and treatment gaps remain, with only half of estimated TB cases among PLHIV reaching care in 2018, only half of estimated PLHIV with TB receiving ART, and less than half of PLHIV new on ART initiating TB preventive
treatment in a subset of countries which reported globally.

On this World TB Day, WHO highlights two key interventions to reduce unnecessary TB deaths among PLHIV:
- (1) provision of TB preventive treatment for all eligible PLHIV; and
- (2) increased uptake of newer diagnostic tests such as the lateral flow urine lipoarabinomannan assay (TB-LAM.)
As the new Director for the Department of Global HIV, Hepatitis and STI Programmes, I support current efforts to continue and to take to scale TB activities. It’s Time for solidarity!

-Meg Doherty, Director Global HIV, hepatitis and STI Programmes, WHO

HIV programmes are encouraged to ensure that TB preventive treatment, including shorter WHO-recommended regimens, with updated guidance launched today, are provided to all eligible PLHIV as part of a routine package of care, including provision of ART, and that treatment completion is ensured.

In recent months, WHO has also released guidelines for use of a bedside urine TB-LAM test to accelerate earlier TB diagnosis, with significantly expanded eligibility criteria. As this test is “point of care” with the potential for earlier
TB diagnosis and treatment initiation, HIV programmes should consider these recommendations as they enhance strategies for TB diagnosis among PLHIV, including as part of a routine package of advanced HIV care.

It’s Time to urgently scale up TB preventive treatment and TB diagnosis and strengthen referral and linkages to TB treatment at HIV service delivery points in all countries and continue to scale-up ART among PLHIV with TB. This applies to all populations
at risk, including children, pregnant women and marginalized groups, to ensure no one is left behind.

WHO calls for continued collaboration in countries across health programmes for harmonized and integrated policies and service delivery, and engagement with communities and other sectors. Unless HIV programmes scale up interventions to close these
gaps in prevention, diagnosis and treatment both for TB and HIV, countries and their development partners will not meet our common target: a 75% reduction in TB deaths among PLHIV between 2010 and 2020. HIV mortality cannot be reduced without addressing
the leading cause: tuberculosis.

Read More
https://www.who.int/news-room/detail/24-03-2020-world-tb-day-2020-it-s-time-for-solidarity

Views: 0
March 25, 2020
New WHO recommendations to prevent tuberculosis aim to save millions of lives
Geneva – New World Health Organization (WHO) guidance will help countries accelerate efforts to stop people with tuberculosis (TB) infection becoming sick with TB by giving them preventive treatment.

A quarter of the world‘s population is estimated to be infected with TB bacteria. These people are neither sick nor contagious. However, they are at greater risk of developing TB disease, especially those with weakened immunity. Offering them TB
preventive treatment will not only protect them from becoming sick but also cut down on the risk of transmission in the community.

As we mark World TB Day 2020, the disease remains the world’s top infectious killer. In 2018, 10 million people fell ill with TB worldwide and 1.5 million people lost their lives to this disease.

“COVID-19 is highlighting just how vulnerable people with lung diseases and weakened immune systems can be,“ said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “The world committed to end TB by 2030; improving prevention is key
to making this happen. Millions of people need to be able to take TB preventive treatment to stop the onset of disease, avert suffering and save lives”.

Dr Tedros highlighted the importance to continue efforts to tackle longstanding health problems, including TB during global outbreaks such as COVID-19. At the same time, programmes already in place to combat TB and other major infectious diseases
can be leveraged to make the response to COVID-19 more effective and rapid.

Although some progress has been made towards targets set at the UN high-level Meeting on TB in 2018, TB preventive treatment has been largely neglected. Global leaders committed to ensuring access to TB preventive treatment to at least 24 million contacts
of people with active TB and 6 million people living with HIV by 2022. To date only a fraction of that target has been reached, with countries putting less than 430,000 contacts and 1.8 million people on TB preventive treatment in 2018.

TB remains the top cause of death among people with HIV. TB preventive treatment works synergistically with antiretroviral therapy to prevent TB and save lives. Reinvigorated efforts by governments, health services, partners, donors and civil society
will be needed to increase access to TB preventive treatment to the levels targeted.

The new consolidated guidelines recommend a range of innovative approaches to scale up access to TB preventive treatment:
- WHO recommends a scale-up of TB preventive treatment among populations at highest risk including household contacts of TB patients, people living with HIV and other people at risk with lowered” immunity or living in crowded settings.
- WHO recommends an integration of TB preventive treatment services into ongoing case finding efforts for active TB. All household contacts of TB patients and people living with HIV are recommended to be screened
  for active TB. If active TB is ruled out, they should be initiated on TB preventive treatment.
- WHO recommends that either a tuberculin skin test or interferon-gamma release assay (IGRA) be used to test for TB infection. Both tests are helpful to find people more likely to benefit from TB preventive treatment
  but should not become a barrier to scale-up access. Testing for TB infection is not required before starting TB preventive treatment in people living with HIV, and children under 5 years who are contacts of people with active TB.
- WHO recommends new shorter options for preventive treatment in addition to the widely used 6 months of daily isoniazid. The shorter options that are now recommended range from a 1 month daily regimen of rifapentine plus isoniazid
  to 3 months weekly rifapentine plus isoniazid, 3 months daily rifampicin plus isoniazid, or 4 months of daily rifampicin alone.
“As people around the globe come together to commemorate World TB Day, WHO is calling on governments, affected communities, civil society organizations, health-care providers, donors, partners and the industry to unite forces and step up
the TB response – notably for TB preventive treatment – to ensure no one is left behind,” said Dr Tereza Kasaeva, Director of WHO’s Global TB Programme. “The new WHO guidance shows the way forward for millions to rapidly
access new tools and shorter, safer options for preventive treatment. The time for action is now.”

TB preventive treatment is an affordable intervention that can prevent families from sliding into poverty and preserve the health and economy of whole communities. WHO anticipates that as new and safer drugs come onto the markets, and as prices
fall, it will become a highly-cost effective way to save millions of lives.

NOTES FOR EDITORS:

WORK BY WHO AND PARTNERS

WHO works closely with Member States including the US Government and technical and funding partners such as UNITAID to enhance access to shorter TB preventive treatment regimens. UNITAID-supported projects such as IMPAACT4TB and Cap-TB projects
enabled by WHO with partners in Brazil, Cambodia, Cameroon, Côte d’Ivoire, Democratic Republic of Congo, Ethiopia, Ghana, India, Indonesia, Kenya, Lesotho, Malawi, Mozambique, South Africa, Uganda, United Republic of Tanzania and
Zimbabwe are leading the way. The new treatment options are also now more affordable, thanks to the significant price drop of rifapentine – a key drug – facilitated recently by UNITAID, the Global Fund to Fight AIDS, Tuberculosis and Malaria
and global biopharmaceutical company Sanofi, along with forthcoming arrangements underway with generic manufacturers.

MORE ABOUT THE GUIDELINES

The new consolidated WHO guidelines come with an operational handbook to help guide countries step-by-step as they take TB preventive treatment to scale. This includes guidance on how to prioritize and invest from demand creation for TB prevention
to supervision and monitoring of the programme.

The guidelines and operational handbook are also accompanied by an innovative mobile application – Prevent TB –to help health-care workers manage TB preventive treatment in their communities. Its online dashboard allows programme
managers to visualize and monitor data in real time. The application can be customized by countries to suit their specific settings and is currently being adopted in India and Philippines.

WORLD TB DAY

The new guidelines and tools are being released ahead of World TB Day. World TB Day is observed on March 24 each year to raise public awareness and understanding about the world’s deadliest infectious killer – TB and its devastating
health, social and economic impact on people around the world. Under the theme “It’s Time”, the spotlight this year is on urgently accelerating the TB response to save lives and end suffering.

Read More
https://www.who.int/news-room/detail/24-03-2020-new-who-recommendations-to-prevent-tuberculosis-aim-to-save-millions-of-lives

Views: 0
March 24, 2020
WHO teams with partners to mitigate the potential impact of the COVID-19 pandemic in malaria-affected areas
The rapid spread of COVID-19 is testing the resilience of robust health systems around the world. WHO and its partners are taking measures to mitigate the potential impact of sustained transmission of the coronavirus in malaria-endemic settings –
particularly in sub-Saharan Africa, which shoulders more than 90% of the global malaria burden.

To date, a small proportion of the global COVID-19 cases have been identified in malaria-affected countries. However, as of 17 March, 25 countries in the African Region had reported cases of COVID-19, and local transmission of the disease had been detected
in 6 countries (Algeria, Cameroon, Kenya, Rwanda, Senegal, South Africa).

“At this point, we still don’t know what the COVID-19 pandemic will look like in sub-Saharan Africa,” said Dr Pedro Alonso, Director of the WHO Global Malaria Programme. “But we do know that when public health emergencies have
hit parts of Africa with weak health systems and high malaria transmission, the impact on malaria disease and death has been very severe.”

The 2014-2016 Ebola outbreak in Guinea, Liberia and Sierra Leone, for example, undermined malaria control efforts and led to a massive increase in malaria-related illness and death in the 3 countries.

Joint action

To support malaria-affected countries, WHO has identified the need for a set of inter-related actions among global partners:
- generating, using and disseminating accurate information;
- mitigating against health system disruptions; and
- ensuring the continuity of routine malaria-specific interventions while also providing, where needed, additional emergency measures, such as mass drug administration, in health systems significantly impacted by COVID-19.
The Organization convened partners on 17 March to discuss areas of collaboration, coordination and next steps.

WHO has begun monitoring the evolving geographic location of COVID-19 cases to understand the extent to which the coronavirus and malaria affect the same target groups. This information will reveal who is likely to be at greatest risk, where and when,
and thus inform the need for malaria-specific interventions to save lives.

In parallel, WHO is working across the 3 levels of the organization to ensure that any advice intended to curb coronavirus transmission and to guide COVID-19 disease management is appropriate in malaria-affected settings.

In recent days, there have been reports of disruptions, as a result of COVID-19, in the production and global supply chains of essential malaria commodities, such as the long-lasting insecticidal nets, diagnostic testing and antimalarial medicines. Coordinated
efforts are required to ensure the availability of key malaria control tools – particularly in countries with a high burden of the disease – and that efforts to limit transmission of COVID-19 do not compromise access to malaria prevention,
diagnosis and treatment services.

Malaria-affected countries may also experience disruptions in health systems in the coming months. A marked increase in febrile patients seeking treatment for COVID-19 at health facilities, for example, would present a significant challenge for a health
workforce that may itself be depleted by the disease.

Policy guidance

WHO is developing guidance for national malaria control programmes and implementing partners to prepare them for the challenges they may face as result of COVID-19.  Among other areas, the guidance will address the mitigation of stockouts of
malaria medicines and commodities; the use of preventive malaria therapy for health workers; the deployment of emergency measures in some settings; and the generation of information relating to the geographic distribution and populations affected
by COVID-19 in malaria-endemic settings.

Restrictions around grouping people together – for training, social and behavior change communication activities, fixed-site distribution and clinical care – as well as the restrictions around movement of people in the country, will require
significant adaptations in order to deliver quality interventions and care.

All people living in malaria-affected areas are advised to follow same precautions as the general population, including: frequent hand-washing, respiratory hygiene, social distancing, seeking prompt medical care if symptoms arise (cough, fever,
difficulty breathing), and other WHO-recommended actions.

WHO stands ready to work with countries and other stakeholders to mitigate the negative impact of the coronavirus on malaria responses worldwide and, where possible, contribute towards a successful COVID-19 response.

About COVID-19

COVID-19 is the infectious disease caused by the most recently discovered coronavirus. This new virus and disease were unknown before the outbreak began in Wuhan, China, in December 2019. Essential information on the COVID-19 pandemic can be found in
a dedicated WHO site.

About malaria

Malaria is a preventable and treatable disease caused by parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes. In 2018, there were an estimated 228 million cases of malaria worldwide and
405 000 malaria-related deaths. For more on malaria, visit: www.who.int/malaria

Read More
https://www.who.int/news-room/detail/18-03-2020-who-teams-with-partners-to-mitigate-the-potential-impact-of-the-covid-19-pandemic-in-malaria-affected-areas

Views: 0
March 19, 2020
Preparing for the unexpected: Why spouses and partners should plan together

In this webcast replay, Vanguard’s Louisa Guthrie, Kevin Wick and Krysta DosSantos will discuss how to best approach wealth planning with your partner or spouse so you’re both prepared to execute your financial plan.

Read More
https://investornews.vanguard/preparing-for-the-unexpected-why-spouses-and-partners-should-plan-together/

Views: 0

March 15, 2020
WHO, UN Foundation and partners launch first-of-its-kind COVID-19 Solidarity Response Fund

GENEVA and Washington, D.C. – A new coronavirus disease (COVID-19) Solidarity Response Fund will raise money from a wide range of donors to support the work of the World Health Organization (WHO) and partners to help countries respond to the COVID-19 pandemic. The fund, the first-of-its-kind, enables private individuals, corporations and institutions anywhere in the world to come together to directly contribute to global response efforts, and has been created by the United Nations Foundation and the Swiss Philanthropy Foundation, together with WHO.

“We are at a critical point in the global response to COVID-19 – we need everyone to get involved in this massive effort to keep the world safe,” said Dr. Tedros Adhanom Ghebreyesus, WHO Director-General. “We are immensely grateful to the UN Foundation and the Swiss Philanthropy Foundation for coming forward to help us set up this fund. A lot of people and institutions have been saying they want to contribute to the fight against the novel coronavirus. Now they can.”

The fund launches with major support already lined up, including from Facebook and Google who have instituted a matching scheme for funds raised through their platforms, while individual donors are also supporting the fund through www.COVID19ResponseFund.org.

“We can’t ignore the fact that this is a truly global problem – one that requires truly global solutions,” said Elizabeth Cousens, UN Foundation President and CEO. “The case for global cooperation could not be clearer – communities everywhere are affected, and people want to contribute. This new fund will create space for people everywhere, together, to fight this virus.”

Funds will go towards actions outlined in the COVID-19 Strategic Preparedness and Response Plan to enable all countries – particularly those most vulnerable and at-risk, and with the weakest health systems – to prepare for and respond to the COVID-19 crisis including rapidly detecting cases, stopping transmission of the virus, and caring for those affected.

WHO and its partners are seeking financing for protective equipment for frontline health workers; to equip diagnostic laboratories; improve surveillance and data collection; establish and maintain intensive care units; strengthen supply chains; accelerate research and development of vaccines and therapeutics; and take other critical steps to scale up the public health response to the pandemic.

The COVID-19 Solidarity Response Fund is hosted by two foundations, the UN Foundation (registered in the United States) and the Swiss Philanthropy Foundation (registered in Switzerland). Both foundations have established relationships with the World Health Organization, allowing for efficient transfer of financial resources to enable COVID-19 response efforts.

Apart from giving online at www.COVID19ResponseFund.org, the UN Foundation can also receive donations via check or wire from around the world by contacting COVID19Fund@unfoundation.org.

All donations made to the United Nations Foundation and Swiss Philanthropy Foundation are tax-deductible to the extent allowable by the law, where applicable (U.S. and Switzerland). Additionally, Swiss Philanthropy Foundation has partnered with Transnational Giving Europe to extend tax benefit to certain additional European countries where applicable.

###

More:

COVID-19 Strategic Preparedness and Response Plan

Coronavirus disease (COVID-19) outbreak information

About the United Nations Foundation

The UN Foundation brings together the ideas, people, and resources the United Nations needs to drive global progress and tackle urgent problems. Our hallmark is to collaborate for lasting change and innovate to address humanity’s greatest challenges. With an insider’s knowledge and outsider’s flexibility, we stay agile to get things done. Learn more at: www.unfoundation.org.

Read More
https://www.who.int/news-room/detail/13-03-2020-who-un-foundation-and-partners-launch-first-of-its-kind-covid-19-solidarity-response-fund

Views: 0

March 14, 2020
Cervical cancer elimination initiative updates

February: Garnering international support on the path to eliminate cervical cancer

On
5 February, the WHO Executive Board recommended to the 73rd World
Health Assembly the adoption of the draft Global Strategy to accelerate
the elimination of
cervical cancer as a public health problem, and urged its
implementation. The proposed resolution urges Member States to implement
the strategy, calling for the support of international organizations
and other relevant stakeholders, and includes a request
for the Director General to support Member states in this endeavor.
The WHA will consider the resolution when it convenes in May 2020. The
session included 23 interventions from EB Member States, most of them
in full support of the Strategy and resolution;
18 from other Member States, 6 observers and 6 non-state actors. Dr
Nono Simelela, ADG and Special Adviser to WHO Director-General Dr
Tedros, responded at the end of the session, thanking delegates for the
broad support, and addressing some of the comments
by sharing some of the ongoing work such as the efforts with the
immunization partners to address HPV vaccine supply challenges and
transparency in pricing.

Read the full story

Read the full draft resolution

Download the
Draft Strategy

Dr Nono Simelela presented the draft Global Strategy towards Eliminating Cervical Cancer as a Public Health Problem during a webinar with partners. This presentation was given as part of
the Us vs. HPV Prevention Week webinar series hosted by the Global
Initiative Against HPV and Cervical
Cancer. While highlighting WHO’s life-course approach to cervical
cancer control, Dr Simelela also explained the proposed elimination
threshold and targets as laid out in the strategy. She also discussed
addressing salient challenges such as redressing inequities
and taking special considerations for women living with HIV.

Read the full story

Listen to the full webinar “Gathering momentum for the global elimination of cervical cancer”

Watch the video: Cervical Cancer Elimination – developed by Basic Health International (BHI), Union for International Cancer Control (UICC) and the Global Initiative Against HPV and Cervical Cancer (GIAHC)

Read the story:To eliminate cervical cancer in the next 100 years, implementing an effective strategy is critical

Dr
Simelela was invited to Rwanda to support the kick off for a national
cervical screening program set to put Rwanda on the path towards the
Global Strategy goals
for elimination of cervical cancer.

Amongst
others, Rwanda’s First Lady Jeannette Kagame received her for a
discussion on how WHO can support efforts against cervical cancer in her
own country and
throughout Africa. Dr Simelela held discussions on cervical cancer
screening and treatment services, including building radiotherapy
capacity, with the dedicated staff of Ruhengeri Hospital, Butaro
Hospital, the Muhoza health center and hospital and the Rwanda
Military Hospital. While cervical cancer and breast cancer are the most
prevalent cancers among the women in the country, Rwanda has
impressively reached a 97% HPV vaccination rate since introducing a
vaccination programme in 2011, with a target to reach 70%
screening coverage in five years. We look forward to a continuing and
fruitful partnership with Rwanda and all the countries who have pledged
their commitment to eliminate this preventable cancer. Together we can
answer WHO’s call and improve the lives of
girls and women around the world.

Follow us for more updates!

Sign up for our newsletter

For
news and real-time updates from around the world,
follow Dr Princess Nono Simelela on Twitter
@DrNonoSimelela
ADG, Special Adviser to the Director-General on Strategic Programmatic Priorities

Upcoming events

International Women’s Day
8 March 2020

64th Session of the Commission on the Status of Women/Beijing+25
9 – 20 March 2020

World Immunization Week
24 – 30 April 2020

Copyright © 2019 World Health Organization, All rights reserved.

You are receiving this email because you signed up for updates from WHO.
Thanks for helping to make the world a little healthier.

Our mailing address is:

World Health Organization

Avenue Appia 20

Geneva 27 1211

Switzerland

If you do not want to continue receiving these e-mails, click here to unsubscribe from this list.

Read More
https://www.who.int/news-room/detail/04-03-2020-cervical-cancer-elimination-initiative-updates-december-2019

Views: 0

March 11, 2020
Ultrathin organic solar cell is efficient and durable

Scientists from the RIKEN, in collaboration with international partners, have succeeded in creating an ultrathin organic solar cell that is both highly efficient and durable. Using a simple post-annealing process, they created a flexible organic cell that degrades by less than 5 percent over 3,000 hours in atmospheric conditions and that simultaneously has an energy conversion ratio—a key indicator of solar cell performance—of 13 percent.

Read More

Views: 0

March 9, 2020
WHO statement on cases of COVID-19 surpassing 100 000

As of today’s reports, the global number of confirmed cases of COVID-19 has surpassed 100 000. As we mark this sombre moment, the World Health Organization (WHO) reminds all countries and communities that the spread of this virus can be significantly slowed or even reversed through the implementation of robust containment and control activities.

China and other countries are demonstrating that spread of the virus can be slowed and impact reduced through the use of universally applicable actions, such as working across society to identify people who are sick, bringing them to care, following up on contacts, preparing hospitals and clinics to manage a surge in patients, and training health workers.

WHO calls on all countries to continue efforts that have been effective in limiting the number of cases and slowing the spread of the virus.

Every effort to contain the virus and slow the spread saves lives. These efforts give health systems and all of society much needed time to prepare, and researchers more time to identify effective treatments and develop vaccines.

Allowing uncontrolled spread should not be a choice of any government, as it will harm not only the citizens of that country but affect other countries as well.

We must stop, contain, control, delay and reduce the impact of this virus at every opportunity. Every person has the capacity to contribute, to protect themselves, to protect others, whether in the home, the community, the health care system, the work place or the transport system.

Leaders at all levels and in all walks of life must step forward to bring about this commitment across society.

WHO will continue to work with all countries, our partners and expert networks to coordinate the international response, develop guidance, distribute supplies, share knowledge and provide people with the information they need to protect themselves and others.

Read More
https://www.who.int/news-room/detail/07-03-2020-who-statement-on-cases-of-covid-19-surpassing-100-000

Views: 0

March 8, 2020
Abu Dhabi, Wizz Air to launch new low-cost carrier

New low-cost airline Wizz Air Abu Dhabi is to launch operations from the United Arab Emirates capital Abu Dhabi in the second half of 2020, the partners in the venture announced Monday.

Read More

Views: 0

March 2, 2020